A new service stores critical digital assets in synthetic DNA, aiming to resist cyberattacks and AI-era data breaches.
Biomemory unveiled DNA Shield, a new service that stores critical digital assets inside synthetic DNA. It’s offline, airgapped storage meant to resist cyberattacks and emerging AI threats.
The idea is to keep high-value data like cryptographic keys or sensitive records in a medium that doesn’t rely on power or networks. Pilot slots run from Oct 15, 2026 through mid-2027, with a full commercial launch planned for 2027. Pricing starts at €10,000 per month for early access.
Biomemory is flipping the usual data center playbook with a new service called DNA Shield. It stores critical digital assets inside synthetic DNA, creating an offline, airgapped vault that can stay changeless and untouchable even as cyber threats evolve.
The idea isn’t new in theory, but Biomemory is turning it into a commercial product. DNA Shield vaults data in DNA strands using an engineered encoding method. The result is a storage medium that doesn’t require power to keep data intact and sits physically out of reach of everyday cyberattacks. In practice, that means cryptographic keys, blueprints, regulatory records or other high-value information could live on DNA for decades, independent of cloud or local servers.
Biomemory’s move into the market follows its March 2026 acquisition of Catalog Technologies, a pioneer in DNA data storage. The combined team is now offering a more mature, industrialized molecular IT platform, rather than a lab demo. The company argues this approach could eventually provide a form of long-term institutional memory that no single vendor or cloud system can reach or alter.
DNA Shield is currently in pilot slots. From Oct 15, 2026 through mid-2027, participating organizations can try the service before Biomemory scales it into a full offering in 2027. The company describes these pilots as a bridge from research to commercial execution, with end-to-end reliability, encoding, secure storage, and recovery, being the focus of the push.
Pricing for DNA Shield starts at €10,000 per month for early access. Biomemory is taking sign-ups directly for those interested in testing the service in this limited phase, signaling a measured approach to bring this technology to broader use.
So what does this mean for everyday people? For most of us, DNA Shield isn’t about replacing your phone’s backup habits. It’s aimed at organizations that need a vault for their most sensitive data, think long-term cryptographic keys, regulatory records, IP, or mission-critical blueprints. It’s a reminder that the tools to protect data can live outside traditional digital infrastructures, potentially offering a form of resilience that’s immune to cyberattacks and even AI-assisted attempts to tamper with information.
What happens next is straightforward: Biomemory will expand pilot slots through mid-2027, then roll out a broader commercial version in 2027. If you’re part of a company weighing cyber resilience strategies, this is one option to watch, though you’ll pay a premium for the added security and longevity that DNA storage promises.
DNA Shield encodes data into synthetic DNA and stores it as a physical molecule. The medium is offline and airgapped, meaning it isn’t connected to networks or power sources that could be hacked. The encoding and authorized recovery steps are designed to be audited and repeatable so organizations can trust the process over time.
Biomemory targets organizations that must protect “cold data”, data that must remain unaltered and accessible far into the future. Early access pricing starts at €10,000 per month, and pilots run through mid-2027 before a broader rollout.
DNA storage is not a plug-and-play substitute for everyday backups. It’s a specialized, offline medium that requires careful handling, decoding, and secure recovery workflows. It’s best viewed as a long-term archival solution for high-value assets, rather than a quick data-retrieval store.
For regular users, the impact isn’t immediate. If you work at a company that guards sensitive keys or critical IP, DNA Shield could become part of a layered security strategy. It signals a growing trend toward physical, non-digital backups that could complement existing cloud and on-site options.
Keep an eye on Biomemory’s pilot programs through mid-2027. If you’re considering this for your organization, start conversations about whether a molecular IT approach fits your risk profile and budget, and prepare for a longer implementation timeline than typical cloud backups.
No. It’s designed as an offline, airgapped option for critical assets, not a general-purpose backup.
Biomemory expects a full service in 2027 after pilot programs run through mid-2027.
Biomemory, following its acquisition of Catalog Technologies in March 2026, is leading the product and its development.
You're reading the quick version.
Read next
cross-border fiber optic scam exposed a 48-core line into Myanmar
Authorities in Thailand uncover a 350-meter, 48-core fiber line feeding a Myanmar scam compound and illegal border casino, highlighting how criminals exploit connectivity.
A Russian suspect tied to a global cyber‑crime gang is detained in Japan and connected to a 2024 hospital hack that disrupted blood testing and may have contributed to a death.
A broad phishing scam tied to political events aims to steal money and personal data as Americans head to the polls.
Data security is about keeping your personal information safe from leaks, misuse, and unauthorized access. Here’s a plain-English guide to how it works and why it matters.
The Daily Brief
Every morning, the news that matters from AI, phones, apps and the people shaping tech. Explained in plain English. Free.
One email a day. No spam, unsubscribe anytime. Privacy policy
